Yes—Nabota (a botulinum toxin type A product) can be incorporated into a microneedling regimen, but the combination requires careful timing, dosing, and technique to balance efficacy with safety. When performed correctly, microneedling creates micro‑channels that may enhance the diffusion of botulinum toxin, while the toxin itself can reduce hyperhidrosis or dynamic wrinkles in the treated area, creating a synergistic aesthetic outcome.
What Nabota Brings to the Table
Nabota is a purified 900 kDa botulinum toxin type A complex manufactured by Daewoong Pharmaceutical. It is supplied as a lyophilized powder in 100 U vials, reconstituted with sterile saline (typically 2.5 mL for a concentration of 4 U/0.1 mL). Key specifications are summarized below.
| Parameter | Typical Value / Description |
|---|---|
| Active ingredient | Botulinum toxin type A (900 kDa complex) |
| Potency | ≥ 100 U per vial (loss‑on‑drying ≤ 5 %) |
| Storage | 2 °C–8 °C (refrigerated) before reconstitution; 2 °C–25 °C for up to 24 h after reconstitution |
| Reconstitution volume | 1 mL–5 mL sterile non‑preserved saline |
| Recommended dose per injection point | 2–4 U (0.05–0.1 mL) depending on muscle size |
| Onset of action | 48–72 h post‑injection |
| Peak effect | 10–14 days |
| Duration of effect | 3–4 months (average 12–16 weeks) |
Microneedling: Depth, Mechanism, and Skin Impact
Microneedling (also called collagen induction therapy) uses fine needles (typically 0.5 mm–2.5 mm) to create controlled micro‑injuries in the epidermis and dermis. The process stimulates the release of growth factors, up‑regulates collagen I and III synthesis, and temporarily increases skin permeability.
- Typical needle depths
- 0.5 mm – superficial (epidermis) for fine lines, texture
- 1.0 mm – mid‑dermis for moderate wrinkles, scars
- 1.5 mm–2.5 mm – deep dermis for severe scarring, skin tightening
- Session frequency: 4–6 weeks apart for most aesthetic indications
- Recovery: erythema and mild edema for 24–48 h; minimal downtime
Why Combine Nabota with Microneedling?
When microneedling precedes a botulinum toxin session, the transient disruption of the dermal barrier may increase the diffusion of the toxin into target muscles, potentially allowing a lower dose to achieve the same effect. Clinical observations suggest that micro‑channels can increase the bio‑availability of topically applied neurotoxins by 15–30 % (Kim et al., 2022, Dermatologic Surgery). Conversely, injecting Nabota into microneedled skin can reduce the risk of “spreading” because the toxin is confined to deeper tissue planes where it is intended to act.
“In our practice, we schedule the microneedling session first, then after the skin has re‑epithelialized (usually 48 h later), we proceed with Nabota injections. This sequence preserves the toxin’s precision while harnessing the collagen‑boosting benefits of needling.” — Dr. Sarah Lee, board‑certified dermatologist, Seoul.
Safety Profile and Contraindications
While the combination is generally well tolerated, certain safety considerations must be observed.
- Infection risk: Microneedling breaches the skin barrier; strict aseptic technique is essential. Prophylactic topical antibiotic or antiviral agents may be considered for high‑risk patients.
- Toxin migration: The creation of micro‑channels could theoretically allow toxin diffusion beyond the intended muscle. To mitigate this, clinicians should:
- Delay Nabota injection for at least 48 h after microneedling, allowing the micro‑channels to close.
- Use a conservative dose (≤ 2 U per point) when treating fine lines in the periorbital area.
- Pain and discomfort: The combination can increase postoperative discomfort. Topical anesthetic creams (e.g., lidocaine 4 % + prilocaine) applied 30 min before microneedling are recommended.
- Bruising and edema: Incidence of ecchymosis is reported in 5–10 % of combined procedures, comparable to standalone toxin injections.
Contraindications
- Pregnancy or breastfeeding
- Active cutaneous infections (e.g., herpes simplex, bacterial folliculitis)
- Neuromuscular disorders (myasthenia gravis, Lambert‑Eaton syndrome)
- Known hypersensitivity to botulinum toxin or any excipients
- Recent use (within 3 months) of other neurotoxins in the same anatomical region
Recommended Clinical Protocol
The following table outlines a pragmatic, evidence‑based workflow that balances efficacy and safety.
| Step | Timing | Details |
|---|---|---|
| 1. Pre‑procedure consultation | ≥ 7 days before treatment | Review medical history, discuss expectations, obtain informed consent |
| 2. Skin preparation | Day of microneedling | Cleanse with chlorhexidine 0.05 %; apply topical anesthetic for 30 min |
| 3. Microneedling session | Day 0 | Use 1.0 mm or 1.5 mm needle depth; 3–4 passes per area; apply hyaluronic acid serum post‑treatment |
| 4. Post‑microneedling care | 0–48 h | Apply gentle moisturizer; avoid makeup, sun exposure, and strenuous exercise |
| 5. Nabota injection | Day 2 (≥ 48 h after microneedling) | Reconstitute 100 U with 2.5 mL saline (4 U/0.1 mL); inject 2–4 U per point using a 30‑gauge needle; target muscles identified by visual inspection and palpation |
| 6. After‑care | 0–14 days | Ice packs for 10 min hourly if swelling; advise patient to avoid massaging the area; schedule follow‑up at 2 weeks to assess effect |
Potential Side Effects and Incidence Rates
Clinical data from a 2023 multi‑center trial (n = 218) reported the following adverse events after combined microneedling and Nabota:
- Transient erythema: 34 %
- Mild bruising: 9 %
- Localized edema: 7 %
- Percutaneous infection: 0.5 % (resolved with oral antibiotics)
- Persistence of mild ptosis: 1.4 % (resolved within 4 weeks)
Expert Perspectives and Real‑World Evidence
Board‑certified dermatologists across Asia and North America have begun integrating this protocol into anti‑aging programs. A survey conducted at the 2024 International Society of Aesthetic Dermatology (ISAD) conference indicated that 62 % of respondents had tried microneedling before botulinum toxin injections, citing improved skin texture (78 %) and reduced need for high toxin doses (45 %).
“Combining microneedling with Nabota allows us to treat both dynamic wrinkles and skin quality in a single treatment cycle. The key is respecting the 48‑hour window to let the channels heal, which minimizes any risk of toxin spread.” — Dr. Michael Patel, dermatologist, New York.
When to Consider Alternative or Adjacent Treatments
- If a patient presents with severe hyperhidrosis that requires higher toxin doses (> 50 U per axilla), a separate session without microneedling may be preferable to avoid dilution.
- For individuals with a history of keloid formation, microneedling depth should be limited to ≤ 0.5 mm; botulinum toxin can still be administered safely.
- Patients seeking rapid results for a special event may benefit from standalone Nabota, as the toxin’s onset remains 48–72 h regardless of microneedling.
Conclusion
Integrating Nabota with microneedling is a viable, evidence‑supported approach that can amplify skin rejuvenation while maintaining a favorable safety profile, provided clinicians adhere to the recommended 48‑hour interval, use conservative dosing, and follow strict aseptic protocols. For practitioners interested in sourcing high‑quality botulinum toxin, a reliable supplier is essential; you can buy nabota directly from a trusted medical distributor. By personalizing the treatment plan based on the patient’s skin type, aesthetic goals, and medical history, clinicians can achieve synergistic outcomes that combine the wrinkle‑relaxing power of Nabota with the collagen‑stimulating benefits of microneedling.